跳至主要内容
临床试验/CTRI/2025/05/087067
CTRI/2025/05/087067尚未招募2/3 期

Effect of preoperative use of intravenous tranexamic acid in reducing blood loss during caeserean section:Double blinded randomised controlled trial

Dr Venisree1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2025年5月26日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
94
试验地点
1
主要终点
TO COMPARE THE DIFFERENCE IN INTRAOPERATIVE BLOOD LOSS DURING C SECTION AFTER PROPHYLACTIC ADMINISTRATION OF 1G IV TRANEXEMIC ACID

研究概览

简要总结

Tranexamic acid (TXA) has been extensively studied for its efficacy and safety in reducing blood loss during and after caesarean section (CS), a procedure associated with increased risk of postpartum hemorrhage (PPH)Regarding safety, TXA administration was associated with a reduced risk of PPH and transfusions, with no significant increase in thromboembolic events . Minor side effects were more common in the TXA group than in the control group, but these were not clinically significant .In conclusion, prophylactic administration of TXA before caesarean section is an effective and safe intervention to reduce blood loss and associated complications. Its use is particularly advantageous in settings where blood conservation is critical and in patients at higher risk of bleeding.

研究设计

研究类型
Interventional
分配方式
Stratified block randomization
盲法
Double Blind Double Dummy

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • pregnant women above 18 years.
  • All consenting women undergoing caeserean section.

排除标准

  • Exclusion criteria Non consenting patients Prior history of Thromboembolism and bleeding disorders Patients on Anticoagulants Acute Fetal Distress •Failed instrumental delivery Exclusion criteria: •Non consenting patients •Prior history of Thromboembolism and bleeding disorders.
  • •Patients on Anticoagulants •Acute Fetal Distress •Failed instrumental delivery.

结局指标

主要结局

TO COMPARE THE DIFFERENCE IN INTRAOPERATIVE BLOOD LOSS DURING C SECTION AFTER PROPHYLACTIC ADMINISTRATION OF 1G IV TRANEXEMIC ACID

时间窗: AFTER 10 MINS OF SKIN CLOSURE

次要结局

  • TO compare need of additional uterotonics drugs & measures(To compare side effects)

研究者

发起方
Dr Venisree
申办方类型
Other []

研究点 (1)

Loading locations...

相似试验